| Patents for C07K - Peptides (3,738) |
|---|
| 07/22/2003 | CA2220515C Process for producing erythropoietin containing no animal proteins |
| 07/17/2003 | CA2514872A1 Purification and characterization of hla proteins |
| 07/16/2003 | EP1326897A2 Humanized anti-lt-beta-r antibodies |
| 07/15/2003 | US6593290 Treatment of inner ear hair cells |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/10/2003 | US20030130496 Immunoglobulins; cloning, amplifying and encoding by DNA sequences, polymerase chain reaction |
| 07/08/2003 | US6590076 Isolated polypeptide, of given sequence, comprising at least an immunogenic portion of a tumor antigen; may be used to generate antibodies |
| 07/01/2003 | US6586570 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/26/2003 | WO2003051272A2 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 06/26/2003 | CA2473890A1 Methods and pharmaceutical compositions for gnrh-i and gnrh-ii modulation of t-cell activity, adhesion, migration and extravasation |
| 06/25/2003 | EP1320540A2 Peptidomimetic protease inhibitors |
| 06/25/2003 | EP1025125B1 Aggregates of human insulin derivatives |
| 06/25/2003 | CN1426423A Humanized antibodies that sequester amyloid beta peptide |
| 06/19/2003 | US20030114659 Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 06/18/2003 | EP1319067A2 Human coagulation factor vii variants |
| 06/18/2003 | EP1319022A2 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |
| 06/12/2003 | WO2003048187A2 Peptides and use thereof in therapeutic agents against hiv infection |
| 06/12/2003 | WO2003048184A2 Flavivirus ns1 subunit vaccine |
| 06/12/2003 | US20030109691 Variant integrin polypeptides and uses thereof |
| 06/12/2003 | US20030108561 Core-glycosylated HCV envelope proteins |
| 06/12/2003 | CA2466413A1 Flavivirus ns1 subunit vaccine |
| 06/11/2003 | EP1317280A2 Vaccine against streptococcus pneumoniae |
| 06/11/2003 | EP1317279A2 Vaccine against streptococcus pneumoniae |
| 06/11/2003 | EP1140993B1 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 06/05/2003 | US20030105021 Using peptide comprising a chain of 7 to 17 contiguous amino acids derived from region of human TNF- alpha from Ser100 to Glu116 or from region of mouse TNF- alpha from Ser99 to Glu115 for manufacture of a medicament for oedema |
| 06/05/2003 | US20030104978 A polypeptide encoded by nucleic acid constructs; recombinant host cell, transgenic animal, transgenic plant; treating blood bleeding, hemostasis |
| 06/04/2003 | EP1196444B1 Extendin-4 conjugates and their medical use |
| 05/30/2003 | WO2003044056A2 Chemically-modified human growth hormone conjugates |
| 05/30/2003 | CA2467731A1 Chemically-modified human growth hormone conjugates |
| 05/29/2003 | US20030100740 Protein for use in the treatment of blood disorders |
| 05/29/2003 | US20030100500 Lowering circulating free fatty acid levels in an individual by administering to polypeptide and carrier |
| 05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
| 05/22/2003 | WO2002022776A9 Human coagulation factor vii variants |
| 05/21/2003 | EP1312609A1 Boronic ester and acid compounds, synthesis and uses |
| 05/21/2003 | EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 05/21/2003 | EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor |
| 05/21/2003 | EP1311542A2 Peptide selection method |
| 05/21/2003 | EP1311282A1 High affinity integrin polypeptides and uses thereof |
| 05/21/2003 | CN1418869A 2-propyl valeramide and 2-propyl pentaenuylamide derivative and application used as anti-convulsion medicine |
| 05/21/2003 | CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates |
| 05/15/2003 | WO2003040170A2 Antibodies to cd40 |
| 05/15/2003 | CA2466128A1 Antibodies to cd40 |
| 05/14/2003 | EP1309691A2 Anti-tnf antibodies, compositions, methods and uses |
| 05/14/2003 | EP1309617A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 05/14/2003 | EP1309607A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 05/14/2003 | CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use |
| 05/08/2003 | US20030087387 Human toll homologues |
| 05/06/2003 | US6559284 Process for purifying a protein |
| 05/06/2003 | US6558661 Inhibiting binding of interferon-gamma to its native receptor |
| 05/02/2003 | EP1305045A1 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 05/01/2003 | WO2002074806A3 New interferon beta-like molecules |
| 05/01/2003 | US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule |
| 04/29/2003 | US6555660 A polypeptide having an amino acid sequence that differs from the preferred granulocyate colony stimulating factor sequence in no more than 15 amino acid residues, and a nonpeptide polymer attached to the amino acid of above polypeptide |
| 04/24/2003 | WO2003033644A2 Peptide useful in immunomodulation |
| 04/23/2003 | CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants |
| 04/16/2003 | EP1301602A2 Fh-binding protein of streptococcus pneumoniae |
| 04/16/2003 | EP0605442B1 Recombinant antibodies for human therapy |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/08/2003 | US6545142 Primers; nucleotide sequence |
| 04/03/2003 | WO2002024909A9 Receptor nucleic acids and polypeptides |
| 04/03/2003 | US20030064922 G-CSF conjugates |
| 04/03/2003 | US20030064914 Copolymer-1 improvements in compositions of copolymers |
| 04/02/2003 | EP0830380B1 Antigenic group b streptococcus type ii and type iii polysaccharide fragments having a 2, 5-anhydro-d-mannose terminal structure and conjugate vaccine thereof |
| 03/27/2003 | US20030060598 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 03/25/2003 | CA2232749C Truncated glial cell line-derived neurotrophic factor |
| 03/20/2003 | WO2003022869A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 03/20/2003 | WO2003022286A1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 03/20/2003 | CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof |
| 03/18/2003 | CA2165694C Erythropoietin analogs |
| 03/13/2003 | WO2003021270A1 Separation and quantification of two beta2 microglobulin isoforms |
| 03/13/2003 | WO2003020762A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 03/13/2003 | WO2003020748A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 03/13/2003 | WO2002030986A3 HUMANIZED ANTI-LT-β-R ANTIBODIES |
| 03/13/2003 | WO2002004494A3 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof |
| 03/13/2003 | WO2001023410A3 Drug target isogenes: polymorphisms in the interleukin 13 gene |
| 03/13/2003 | US20030049725 Anti-TNF antibodies, compositions, methods and uses |
| 03/13/2003 | CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 03/12/2003 | EP1290178A2 Corynebacterium glutamicum genes encoding stress, resistance and tolerance proteins |
| 03/04/2003 | US6528486 Peptide agonists of GLP-1 activity |
| 02/27/2003 | WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine |
| 02/27/2003 | WO2002064617A3 Method and system for haplotype reconstruction |
| 02/22/2003 | CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 02/20/2003 | WO2003014308A2 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/20/2003 | CA2454246A1 Cysteine mutants and methods for detecting ligand binding to biological molecules |
| 02/06/2003 | WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/05/2003 | EP1280912A2 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same |
| 01/23/2003 | US20030017134 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/16/2003 | WO2002004021A9 Treatment of b cell malignancies using combination of b cell depleting antibody and immune modulating antibody related applications |
| 01/16/2003 | US20030012790 Especially bispecific molecules comprising an IFN- gamma inhibitor and a further specificity to a target involved in the initiation or development of IBD, including ulcerative colitis and Crohn's disease. |
| 01/16/2003 | US20030012787 Especially for ulcerative colitis and Crohn's disease. |
| 01/15/2003 | CN1391581A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/14/2003 | CA2114313C Bpc peptides, their preparation and use |
| 01/03/2003 | WO2002066056A3 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 12/31/2002 | US6500422 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (LAG-3) |
| 12/27/2002 | WO2002102299A2 Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 12/26/2002 | US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 12/26/2002 | US20020197675 Glial nerovus system modulator for use in the treatment of nervous system disorders and spine damage |
| 12/25/2002 | CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity |
| 12/19/2002 | WO2002074785A3 Method and composition for decreasing the tryptophan concentration in the blood of mammals |
| 12/19/2002 | WO2002004665A3 Method with a wide range of applications, for identifying modulators of g-protein-coupled receptors |